NIH-funded research R21 grant

Understanding how specific cells help muscles heal after injury

Official title: Fibroadipogenic progenitor cells as drivers of angiogenesis during muscle regeneration

Funded at University of Missouri-Columbia · NIH-10741438 · Data updated 2026-11-12

This study is looking at how certain cells in your body help muscles heal after injuries, especially in your arms and legs, to find ways to improve recovery and create better treatments for muscle injuries.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Missouri-Columbia
NIH-funded
Lab location1 site (Columbia, United States)
Project startSeptember 19, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$420,883
NIH project number1R21HD110771-01A1
Project IDNIH-10741438 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced significant muscle injuries, particularly those resulting in volumetric muscle loss.

Less likely to help

Patients with minor muscle injuries or those whose injuries do not involve significant tissue loss may not benefit from this research.

What this research studies

This research investigates the role of fibroadipogenic progenitor cells in the healing process of skeletal muscle after traumatic injuries, particularly in the limbs. By using a novel mouse model, the study aims to uncover the cellular and molecular mechanisms that differentiate between successful muscle regeneration and cases where regeneration fails. The approach involves analyzing the interactions between various cell types, including muscle stem cells and endothelial cells, to better understand how to enhance muscle recovery. This knowledge could lead to new therapies that activate the body's natural healing processes.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for individuals with severe muscle injuries, enhancing their recovery and quality of life.

How similar studies have gone: Previous research has shown promise in understanding muscle regeneration, but this specific approach focusing on fibroadipogenic progenitor cells is relatively novel.

Where this research is happening

  • University of Missouri-Columbia
    Columbia, United States
    Active

Researchers

  • Principal investigator: Segal, Steven S — University of Missouri-Columbia
  • Study coordinator: Segal, Steven S

Related research

Other NIH-funded projects on the same topics.

  • Boosting immune response to fight cancer

    This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-9868156

  • Interface between immune cells and scarring in the eye

    This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11609392

  • Understanding cell-cleanup problems in C9ORF72-related ALS/FTD

    Researchers are studying why the body's cell-cleanup systems fail in a genetic form of ALS/FTD to pave the way for better treatments.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11606636

  • Molecular clues to endometriosis-related infertility

    This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11595518

  • A universal Shigella vaccine using SAVE to protect people of all ages

    A new vaccine approach called SAVE aims to prevent Shigella-related dysentery across all ages, including children and adults, by targeting conserved bacterial components.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11464403

  • Biomarkers that predict osteoarthritis risk in people at higher risk

    A long-term study will look for protein markers in body fluids that could predict who will develop knee osteoarthritis before symptoms appear.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11461903

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.